In these studies, the majority of MM cases possessed overexpression of the positive NF-κB regulators NIK, TACI and CD40, or reduced or silenced activity of the negative NF-κB regulators TRAF2, TRAF3 and cIAP1/2. This evidence concerns the gene TRAF3 and Miyoshi myopathy.